Prognostic Value of Post-ischemic Stunning As Assessed by Gated Myocardial Perfusion Single-photon Emission Computed Tomography: a Subanalysis of the J-ACCESS Study
Overview
Authors
Affiliations
Background: To determine the prognostic value of post-ischemic stunning, the Japanese assessment of cardiac event and survival study by quantitative gated myocardial single-photon emission computed tomography (SPECT) (J-ACCESS) study was reevaluated.
Methods And Results: Of the 4,031 patients of the J-ACCESS, the present study evaluated 1,089 who completed gated SPECT both after stress and at rest. To assess post-ischemic stunning, the following measurements (left ventricular volumes after stress minus volumes at rest) were made: Deltaend-systolic volume (DeltaESV), Deltaenddiastolic volume (DeltaEDV) and Deltaejection fraction (DeltaEF). Myocardial stunning defined either as DeltaESV >or=5 ml, DeltaEDV >or=5 ml or DeltaEF <or=5% was observed in 21%, 22%, or 26%, respectively. During a 3-year follow-up, 101 cardiac events occurred. Kaplan-Meier survival estimation indicated worse event-free survival rates in patients with dilated ESV, dilated EDV, LVEF <or=45%, DeltaESV >or=5 ml or DeltaEDV >or=5 ml than in those without, whereas DeltaEF <or=5% did not predict events. Multivariate analysis demonstrated that LVEF <or=45% was the independent predictor for cardiac events. Nevertheless, DeltaEDV >or=5 ml was also an independent parameter, in addition to LVEF <or=45%, to predict the combined endpoint of cardiac death, myocardial infarction, and revascularization, but excluding heart failure.
Conclusions: These results indicate that post-ischemic stunning, as assessed by gated SPECT, is a marker for poor prognosis, particularly for ischemic cardiac events.
Tanaka Y, Yoda S, Fukumoto K, Hatta T, Kuronuma K, Suzuki Y Intern Med. 2024; 63(20):2739-2750.
PMID: 38432965 PMC: 11557194. DOI: 10.2169/internalmedicine.3039-23.
The evolution of the prognostic value of regadenoson SPECT myocardial perfusion imaging.
Sidhu G, Hendel R J Nucl Cardiol. 2020; 28(6):2808-2811.
PMID: 32468300 DOI: 10.1007/s12350-020-02208-y.
Bestetti A, Cuko B, Gasparini M, De Servi S J Nucl Cardiol. 2018; 27(1):137-146.
PMID: 29951894 DOI: 10.1007/s12350-018-1340-6.
Chen G, Qiao Y, Ma J, Wang J, Hei F, Yu J Chin Med J (Engl). 2018; 131(12):1436-1443.
PMID: 29893360 PMC: 6006813. DOI: 10.4103/0366-6999.233946.
Benz D, Giannopoulos A J Nucl Cardiol. 2018; 26(5):1717-1719.
PMID: 29589207 DOI: 10.1007/s12350-018-1263-2.